The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Regulatory News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.80
Bid: 3.70
Ask: 3.90
Change: 0.15 (4.11%)
Spread: 0.20 (5.405%)
Open: 3.65
High: 3.80
Low: 3.65
Prev. Close: 3.65
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Director

22 Jan 2007 07:01

Fabian Romania Property Fund Ltd22 January 2007 22 January 2007 Fabian Romania Property Fund Limited ("Fabian" or the "Fund") Resolution toAppoint a Director subject to formal approval of the Jersey Financial ServicesCommission ("JFSC") Fabian, the AIM listed property fund established to invest in Romanian property,has resolved to appoint Mark Houslop to the Board of Fabian subject to theapproval of the JFSC. Nicholas Mark Houslop, 58, joined the firm of surveyors DTC in 1973 and became apartner in 1979 and a Director in the company when it became publicly listed(DTZ) in London in 1987. His experience has extended from the UK and Europeanmarkets to the USA where he set up and ran the firm's New York office for fiveyears advising on major real estate investments in New York, Washington D.C,Houston, Denver, San Francisco and Los Angeles. In the UK he has advised on many central London properties including The Lloydsof London headquarters, The Berkeley Square Estate and The Plaza Shopping Centreand UK House both major blocks on Oxford Street, as well as developments inLondon Docklands. Mr Houslop sits on the supervisory board of the German publicly listedresidential/commercial property company IMW and is a fellow of the RoyalInstitution of Chartered Surveyors. Mark Houslop's conditional appointment marks a significant milestone in theimplementation of Fabian's strategy to bolster its Board following admission toAIM on December 15 last year. Commenting on today's appointment, Mark Holdsworth, Director of the Fund said: "Mark Houslop has over 30 year's experience of the property industry. He set upDTZ's US business. Mark will be a valuable addition to Fabian and we aredelighted to have him join the Board" Listed below are the names of all companies of which Mark Houslop has beendirector and all partnerships in which he has been a partner at any time in thepast five years: Current directorships and partnerships Past directorships and partnerships IMW Immobilien AG None There are no further details required to be disclosed in relation to thisappointment pursuant to Rule 17 and Schedule 2, paragraph (g) of the AIM Rules. For further information, please contact: Fabian Romania Property Fund LimitedMark Holdsworth 020 7499 9988 Shore Capital Stockbrokers LimitedDru Danford 020 7408 4090 Deloitte Corporate FinanceJames Lewis 020 7936 3000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Jan 20232:05 pmRNSSecond Price Monitoring Extn
9th Jan 20232:00 pmRNSPrice Monitoring Extension
9th Jan 202311:05 amRNSSecond Price Monitoring Extn
9th Jan 202311:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSHalf-year Report
24th Nov 20227:00 amRNSNotice of Results
31st Oct 20221:47 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSBlock admission six monthly return
23rd Sep 202211:44 amRNSResult of AGM
20th Sep 20221:36 pmRNSDirector/PDMR Shareholding
15th Sep 20223:41 pmRNSGrant of options
14th Sep 20222:05 pmRNSSecond Price Monitoring Extn
14th Sep 20222:01 pmRNSPrice Monitoring Extension
6th Sep 20227:00 amRNSGrant of options
1st Sep 20227:00 amRNSNotice of AGM and Director change
23rd Aug 20227:00 amRNSFinal Results
9th Aug 20227:00 amRNSBispecific designs patent application
5th Aug 20224:41 pmRNSSecond Price Monitoring Extn
5th Aug 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSAppointment of Chief Executive Officer
6th May 20227:00 amRNSTrading update
1st Apr 20227:00 amRNSBlock admission six monthly return
14th Mar 20227:00 amRNSUpdate on Board changes
28th Feb 20227:00 amRNSDirector changes
22nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20224:35 pmRNSPrice Monitoring Extension
21st Feb 20227:00 amRNSDirectorate Change
10th Feb 202212:49 pmRNSStmnt re Share Price Movement
14th Jan 20227:00 amRNSFormation of New Scientific Advisory Panel
11th Jan 20221:26 pmRNSHolding(s) in Company
31st Dec 20217:00 amRNSTotal Voting Rights
16th Dec 20217:00 amRNSExercise of share options and total voting rights
14th Dec 20217:00 amRNSExercise of share options and total voting rights
6th Dec 20217:00 amRNSHalf-year Report
2nd Dec 20217:00 amRNSUpdate on R&D
17th Nov 202110:00 amRNSNotice of Results
19th Oct 20214:25 pmRNSGrant of options
7th Oct 20214:40 pmRNSSecond Price Monitoring Extn
7th Oct 20214:35 pmRNSPrice Monitoring Extension
7th Oct 20212:06 pmRNSSecond Price Monitoring Extn
7th Oct 20212:00 pmRNSPrice Monitoring Extension
7th Oct 202111:06 amRNSSecond Price Monitoring Extn
7th Oct 202111:00 amRNSPrice Monitoring Extension
7th Oct 20217:00 amRNSNew contract win
27th Sep 20217:00 amRNSTotal Voting Rights
24th Sep 202112:00 pmRNSResult of AGM
24th Sep 20217:00 amRNSAGM Statement
1st Sep 20217:00 amRNSNotice of AGM
31st Aug 20215:00 pmRNSTotal Voting Rights
24th Aug 20217:00 amRNSCollaboration with Eurofins Discovery

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.